chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is not an AE.  Patient was inadvertently given the Moderna vaccine instead of the Pfizer at age 12.  patient has not experienced any affects from the vaccine.
High fever, 3 hours of constant shaking, arm pain, arm pit pain, diarrhea for about 24 hours
large red patch on the upper arm with a blue center, Nodule felt underneath the skin at the center. Painful when touched and warm to touch.
After my 2nd dose I was able to lift my arm unlike after my first dose; large red rash around injection site; This spontaneous case was reported by a non-health professional and describes the occurrence of INJECTION SITE RASH (large red rash around injection site) and LIMB DISCOMFORT (After my 2nd dose I was able to lift my arm unlike after my first dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE RASH (large red rash around injection site) and LIMB DISCOMFORT (After my 2nd dose I was able to lift my arm unlike after my first dose). At the time of the report, INJECTION SITE RASH (large red rash around injection site) had resolved and LIMB DISCOMFORT (After my 2nd dose I was able to lift my arm unlike after my first dose) outcome was unknown.            Concomitant drugs are not provided Treatment information not provided.   This case was linked to MOD-2021-214817 (Patient Link).
Left arm swollen, red, tender, some complaints of numbness.  Has appt to see the doctor this morning 8/13/10. Has been giving ibuprofen and applying ice to arm.
Information has been received from a 55 year old nurse practitioner with a history of chickenpox who reported that she was preparing to administer ZOSTER (Oka/Merck) to a patient "a few days ago when a few drops of the vaccine flew into the air as she processed up on the plunger to remove air from the syringe.  The drops of ZOSTER (Oka/Merck), landed on her desk.  She was not aware of any topical exposure to the ZOSTER (Oka/Merck) at the time.  On 27-AUG-2008, the nurse practitioner noticed she had developed two clusters of vesicular lesions on her left forearm.  She then reported that the lesions were two clusters/rash of red, raised shiny bumps on her left forearm.  There was no vesicular fluid.  Later on 28-AUG-2008 the NP reported that her lesions were starting to vesiculate.  At the time of the report, the patient's vesicular lesions persisted.  The NP agreed to participate in the VZVIP program.  No further information is available.
15 minutes after receiving vaccination I got a tingling sensation in my throat and then it felt like a lump in my throat.  EMS was called and I received Benadryl and prednisone. 9 days later I saw my general practitioner  9 days later because my throat was still swollen.  She prescribed me Pepcid and I have to go for a thyroid ultrasound.
This spontaneous report as received from a health care worker refers to a unspecified number of patients of unknown age. The patients medical history was not reported. On an unknown date the patient was vaccinated with RECOMBIVAX HB. Concomitant medications were not reported. On an unknown date the unspecified number of patients received RECOMBIVAX HB doses that were stored at 34 Fahrenheit (F) for 7 hours. No adverse effects were reported. The outcome of received RECOMBIVAX HB doses that were stored at 34F for 7 hours and no adverse effects reported was unknown. The healthcare worker stated that no patient or lot information was available. This case is linked to 1406USA003227, 1406USA003840, 1406USA003841 and 1406USA003842 (same reporter link). Additional information has been requested.
presented w/ c/o inability to swallow, states unable to since flu shot given earlier, noted hoarseness refer to ER-given DPH & Depomedrol; recover immed & return to clinic 40mins later;
pt recvd vax OCT92 & in NOV92 pt devel yeast infect w/crusting of skin on hands, thighs & arms which was described by dermatologist as erythematous, hyperpigmented, scaly plaques; devel pruritus as well;
This spontaneous report received from a patient concerned a 26 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non-smoker, and non-alcoholic, and other pre-existing medical conditions included the patient had no known allergies and no history of drug abuse or illicit drug use.The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986, and expiry: 15-JUNE-2021) dose was not reported, administered on 15-JUNE-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-JUNE-2021, the subject experienced tired/feeling drained. The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tired/feeling drained. This report was non-serious.
Patient has a bone marrow transplant in October 2022 and was to restart his Moderna vaccines due to them being depleted.  Patient should have restarted with Moderna (1st and 2nd doses) but instead received the bivalent covid 19 booster.  After researching and per the CDC we are going to be restarting the primary series as soon as we get the vaccine in, and we will restart the series.
My daughter is only 17 years old she is studying in the medical field she's been playing tennis for four years she had to stop doing all of that because September 21 she was in class and she got three seizures she hasn't been able to keep focus her eyes are very dry and droopy her eye shape has changed she's always tired I had to get her out of school because she cannot focus she seems to lose her concentration she is a good student because of this she will be losing time in school she has major headaches every day because of this vaccine Pfizer my daughter has been having sizers she's was normal child with lots of energy and not a sick baby now with my heart in my hand now all these doctors are running different test
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. 16-OCT-2014, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. During 2016, the patient was treated at a hospital for a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX, vaccine, and/or despite receiving ZOSTAVAX, for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
After vaccination, patient started feeling chills, fever, fatigue. After a few days had general weakness, stomach pain. Developed bilateral lower extremity weakness and urinary retention. Was admitted to the hospital for encephalomyeloradiculitis, and eventually sent out to rehab once stable. Most recently seen in Neurology clinic 8/2022, with current working diagnosis as post-Shingrix reaction, as all other workup for infectious/autoimmune etiologies have returned negative.
The caller reported being unaware of any adverse experience following administration of the vaccine; The caller reported a supported temperature excursion overnight (11AUG2021-12AUG2021) for VAQTA with subsequent administration (12AUG2021 "around lpm") to a consumer; This spontaneous report was received from a nurse and refers to a 63-year-old female patient. No information regarding her pertinent medical history, drug reactions or allergies and concomitant therapies was provided.   On 12-AUG-2021 around 13:00, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) injection in prefilled syringe, lot # T034003 (lot number was verified to be valid), expiration date: 28-MAR-2022, 1 milliliter (injection site and route of administration were not provided) for prophylaxis.  The administered dose experienced a temperature excursion of 75.7 degrees Fahrenheit for 1 hour and 3 minutes overnight (11-AUG-2021-12-AUG-2021). No previous temperature excursion had occurred. No additional adverse events were reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: devicelotnumber: T034003; expirationdate: 28-MAR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
No adverse events per parent - contacted on afternoon 10/31/2007. Reporting due to Influenza Vaccine administered before 6 mo. of age per recommendation of CDC Info. Contact Service #1-43674577.
Patient began with onset of cold symptoms which 3-4 days later progressed to a rash on the trunk of the body with blister like centers.
This spontaneous prospective pregnancy report was received from a pharmacist referring to a female patient of unknown age. The patient did not have medical history, concurrent conditions or drug reactions/allergies. On 18-JAN-2018, the patient was vaccinated with a dose of VARIVAX, subcutaneous (strength, dose number, lot number and expiration date were not provided) for prophylaxis. Concomitant therapies included iron (unspecified), minerals (unspecified), vitamins. It was reported that on 18-JAN-2018, the patient was in her "first trimester of pregnancy." The patient was still currently pregnant. The LMP (last menstrual period) was unknown (also reported as: "first trimester". The pregnancy outcome was outcome pending. No laboratory diagnostics or studies were performed.
Approximately September 2016 developed worsening behavior difficulties, with uncontrolled outbursts causing severe school problems and home problems and requiring psychiatric evaluation. Symptoms of ADHD.
sore arm; This is a spontaneous report from a contactable consumer. A 35-year-old female patient (daughter) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, batch/lot number: EL1283; expiration date: 30Apr2021), via an unspecified route of administration, administered in Arm Left on 21Jan2021 at 14:00 as 1ST single dose for covid-19 immunization (at the age of 35-years-old). The patient had no medical history including any illness at time of vaccination and there were no concomitant medications. It was reported that after receiving the first dose of vaccine on 22Jan2021 the patient experienced sore arm for a couple of days. She did not have any pain the first day. Mentions her daughter only had a sore arm for a couple of days. The outcome of the event was recovered on 23Jan2021.  Follow-up attempts are completed. No further information is expected.
immediately after the injection I felt woozy, weakness and as the day progressed the dizziness occurred. I then got a headache which never went away for 3 days. I do have  disequilibrium but had no idea that this shot would affect me like that. These side effects have lasted 3 days, Also my arm below the injection site swelled up and had a rash. I was pretty much homebound for the 3 days. As the reaction was right away, it never subsided. Today day 4 a little relief. I took Advil for the headache. I never get headaches. This has been a very bad experience for me and I don't think I want to get shot again!
Narrative:  Patient received the two Pfizer vaccines in Jan 21 and Feb 21. The patient tested positive for COVID 19 on 3 September 2021 and was hospitalized with COVID 19 pneumonia and hypoxia. The patient was treated appropriately. The patient died of complications to COVID 19 pneumonia on 15 September 2021.
A MA reported that a 79 year old female received an injection of Pnu-Imune 23 on 10/17/00 and within a few hours, post vax, she developed an injection site reaction characterized by swelling, heat, redness and pain. It was also reported that this pt had received a dose of Pnu-Imune 23 in 1994. This is 1 of 3 pts from this facility who had an adverse experience following receipt of Pnu-Imune 23, lot 463015.
About 10-13 days after receiving my 3rd dose, I began to have dispersed dermatographism over my entire body. At first I thought it was just physical urticaria from some environmental cause, but it continued for the past 10 days or so. I have not had any other changes in diet, environmental exposure, changes of soap/laundry detergent, bug bites or any such events. I have narrowed it down to likely as a result of a likely increased hyperactive inflammatory response due to vaccine.  Of course with all dermatographism, it's hard to say the cause, but I figured I should document it here. If it doesn't resolve in another week, I shall seek assistance from my physician.
A non-serious spontaneous report of gave 1/2 dose of H1N1 was received from a consumer concerning a 20-year-old female. On 27-Oct-2009 the patient received 1/2 dose (0.1 ml) of H1N1, Intranasal in a single nostril. The other half of the dose was discarded by the person administering the vaccine. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
45mm x 70mm reddened, raised area on right upper arm. Patient states area is sore but does not itch.
occlusive DVT involving left lower extremity extending from the left common femoral vein through the femoral vein and popliteal vein: Patient noticed L groin pain when getting up after resting after a bike ride. Pain significantly worsened overnight and leg more red than right leg on exam with tenderness of groin. Venous duplex showed extensive left lower extremity DVT. Patient sent to ER for further evaluation and treatment. Patient denied any shortness of breath or chest pain. pulse ox 98%, pulse 88 bpm.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concomitant products included INSULIN and METFORMIN HCL for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced HEADACHE (Headache). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
I have had severe bruising and lumps on my arm since receiving vaccine.  i  I was unable to sleep on my left side for 3 weeks after receiving it.
colds/flu/headache sxs started about Feb 5, 2021  called number listed and spoke to pt herself. pt states she had fever and chills this past saturday and sunday. pt was tested for covid monday and was just contacted she was covid positive (unsure test performed). pt today only has nasal congestion. she has not contacted pcp about her positivity. she inquiring about her son who has downs syndrome and has a heart condition. rec: contact pcp for further treatment and or therapies, quarantine herself, wear masks, wash hands, and have son stay with family and limit exposure to her. contact his md for  possible vaccination.
parent phoned MD p/hr w/c/o swelling of upper & lower lips w/blisters on both lasting a few hr;resolved on own w/o treatment;seen in office day p/back to nl;
Had common side effects for two days.  After seven days, I noticed a dime-sized redness surrounding injection site.  Three days later, the red area is 3" in diameter.  The original injection site has continued to be painful.  Now the reddened area itches.
Fever, Headache, Body aches, Sun and Heat sensitivity, Fluid retention - swelling in hands, fingers and lower extremities - symptoms lasted approximately 2 weeks.   Heavy chest - Right side and Difficulty breathing when laying down - still present at time of report.
Migraine headache for 30 hours. Arm so sore he had to pick it up with other arm at times
Pt developed a maculopapular rash. A similar rash developed in twin and another pt that had vaccines from the same lot of MMR and Varivax.
pt developed a fine, maculopapular rash over her whole body 30 mins after immunizations. according to mother she also developed lethargy, In office, all vital signs were normal. rash disappeared in 2 days.
This spontaneous report as received from a medical assistant refers to a 9 month old patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 06-SEP-2016, the patient was inadvertently vaccinated with PROQUAD (dose and route unknown) from lot # M006101 with expiry date of 01-AUG-2017 at the age of 9 months. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
fatigue; body aches; This is a spontaneous report from a contactable consumer, the parent. A 26-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on 27Mar2021 at 06:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was none. The patient received medication for birth control (unspecified) within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on 06Mar2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Mar2021, the patient experienced fatigue and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of events fatigue and body aches were resolved on an unknown date.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Both times arm hurt; I had chills; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain in extremity (received 1st dose on an unknown date, refer case US2022AMR081295).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm and chills. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the chills was unknown.   It was unknown if the reporter considered the pain in arm and chills to be related to Shingles vaccine.  Linked case(s) involving the same patient: US2022AMR081295   Additional Information: GSK Receipt Date: 18-MAY-2022 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient had no reaction with the first shingles shot.  The patient had chills that night after having the second shot of shingles. The patient arm was hurt both times for a while. Additional Supportive Information: The follow up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR081295:Same reporter.
Fever 101.3 F and Swelling and redness on ears and bridge of nose
"a few days" after the MMR and Varicella and Comvax shot were given at the 12 mo visit, patient had a red, bumpy rash all over which lasted for "a week". The rash also spread to a visiting uncle and lasted about the same time. Mother also noticed her cheeks were swollen. She did not require medical attention.
102.7 fever; 103.5 fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (103.5 fever) and PYREXIA (102.7 fever) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PYREXIA (103.5 fever). On 10-Feb-2021, the patient experienced PYREXIA (102.7 fever). At the time of the report, PYREXIA (103.5 fever) and PYREXIA (102.7 fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: TCR document was attached. No new information was provided.
1st dose on 2019, 2nd dose not administered; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 16th October 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.      Additional Information: GSK receipt date: 05-OCT-2022 Reporters comment:  The 2nd dose had not been administered yet. Pharmacy did not keep record of vaccine lot number or expiration date. The Vaccine Administration Facility is the same as Primary Reporter. Consented to follow up.  Additional Supportive information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination
Patient  received 1st dose 3/5/21 @15:33 in left deltoid.  Reports diarrhea starting within 2 hours on same date that self resolved but reoccurred 3/18 and continues intermittently to date of report.  Also reports vomiting beginning 3/9 and lasting through 3/13 but self resolved.  Also reports fatigue beginning 3/7 that continues to date of report.  Also reports rash at injection site beginning Day 10 post injection that lasted for 2 days.  Also reports soreness at injection site from 3/6 - 3/7.  Patient denies fever, chills and headache.
Rash on arms, legs and back that began about 6-19-15. Mom tried over the counter ointment (steroid). Saw MD on 7-8-15 diagnosed with erythema multiforme and started on prednisone.
Headache started fairly quickly but not as bad as first dose. Arm was sore. No chills. Headache lasted for the rest of the day. Arm soreness lasted quite a few days - about 5 days or so. Still continuing to have heart racing and pounding and heartburn pain up in my chest. Those heart symptoms haven't gotten noticeably better until about this last week.  Cardiac Nurse Practitioner - saw her on January 25th  - taking PEPSID. l. GI assessment will be this Tuesday, the 9th of March - I will be having that at the medical center.